GlaxoSmithKline

Safe-Biopharma launches cyber security consulting service for life science, healthcare

Friday, April 24, 2015 01:18 PM

SAFE-BioPharma Association has created SBP Digital Trust Consulting, a resource of internationally recognized identity and access management (IAM) policy and technical experts for life science and healthcare companies seeking to develop improved cyber security strategies.

More... »

Quest Diagnostics

NewLink Genetics, Merck receives Vaccine Industry Excellence Awards

Friday, April 17, 2015 01:09 PM

NewLink Genetics, a biopharmaceutical company focused on bringing novel immunotherapeutic medicines to cancer patients globally, and Merck received two Vaccine Industry Excellence (ViE) awards presented during the 15th Annual World Vaccine Congress. The ViE Awards honor the efforts, accomplishments and positive contributions of companies and individuals in the vaccine industry.

More... »


ALS Association, Harvard, Massachusetts General collaborate with GSK

Friday, April 17, 2015 12:56 PM

The ALS AssociationHarvard Stem Cell Institute and Massachusetts General Hospital Neurological Clinical Research Institute are collaborating with GlaxoSmithKline on a clinical trial to evaluate the potential of an anti-epileptic drug in ALS patients. In parallel testing, brain cells will be made from each patient's stem cells to see if they can predict which patients might respond to the medicine.

More... »

Incyte joins Safe-Biopharma Association

Friday, April 17, 2015 12:39 PM

Incyte, a Delaware-based biopharmaceutical company, has joined SAFE-BioPharma Association, a nonprofit industry coalition responsible for the ongoing development and implementation of the SAFE-BioPharma digital identity and signature standard.

More... »

GSK to establish global vaccines R&D center in the U.S.

Monday, April 6, 2015 11:57 AM

GlaxoSmithKline is establishing a new global center for vaccines R&D in Rockville, Md. The site will become one of three global vaccines R&D centers for GSK, complementing the company’s existing global R&D center in Rixensart, Belgium and in Siena, Italy, a site GSK acquired from Novartis last month.

More... »

Clinicians, researchers and industry collaborate with the 100,000 Genomes Project

Friday, March 27, 2015 11:12 AM

Genomics England has announced a new collaboration as part of the 100,000 Genomes Project to accelerate the development of new diagnostics and treatments for patients. Ten pharma and biotech companies have come together to create the Genomics Expert Network for Enterprises (GENE) Consortium to oversee a year-long industry trial.

More... »

GSK's 2015 Discovery Fast Track Challenge seeks early drug discovery partnerships

Thursday, March 26, 2015 02:54 PM

GlaxoSmithKline is encouraging academic scientists in Europe, Canada and the U.S. to submit their novel early drug discovery research proposals into its third annual Discovery Fast Track Challenge—a program designed to accelerate the translation of early-stage research into game-changing new medicines. The challenge provides a new template for drug discovery as it seeks to rapidly uncover the best opportunities for discovery research.

More... »

Cold Spring Harbor Laboratory, GSK to develop diabetes and obesity therapeutic

Monday, March 23, 2015 03:40 PM

Cold Spring Harbor Laboratory (CSHL), based in New York, has inked a collaboration with GlaxoSmithKline to develop a treatment for obesity and type 2 diabetes.

More... »

Moderna appoints Tal Zaks as chief medical officer

Thursday, March 19, 2015 01:22 PM

Moderna Therapeutics, a developer of messenger RNA (mRNA) Therapeutics across a range of therapeutic applications, has announced that Tal Zaks, M.D., Ph.D., will join Moderna's executive leadership team as chief medical officer.

More... »

$100M invested in new Dementia Discovery fund

Wednesday, March 18, 2015 01:11 PM

The U.K. government has announced over $100 million will be invested in a pioneering new global Dementia Discovery Fund. Major pharmaceutical companies Biogen Idec, GlaxoSmithKline, Johnson & JohnsonEli Lilly and Pfizer have all committed in principle to investing in the project, alongside Alzheimer's Research U.K. and the U.K. government.

More... »


CWWeekly

May 4

Walgreens leverages its 100 million customer database in patient recruitment deal with five big pharma companies

Synchrogenix partners with CISCRP on transparency, developing lay language trial summaries for participants

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

May

Job satisfaction mixed as workload increases
Salaries not keeping pace with rise in work, responsibilities

Gamification moving from early science to patient use
Pharma looking to use games for early diagnosis, recruitment, adherence

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs